- Home
- MNTK vs ORMP Comparison
MNTK vs ORMP Comparison
Compare MNTK & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNTK | ORMP |
|---|---|---|
| Founded | 1980 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.0M | 165.3M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MNTK | ORMP |
|---|---|---|
| Price | $1.75 | $4.02 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.80 | N/A |
| AVG Volume (30 Days) | 176.8K | ★ 516.0K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 0.91 |
| Revenue | ★ $176,382,000.00 | $2,000,000.00 |
| Revenue This Year | $18.55 | N/A |
| Revenue Next Year | $12.68 | N/A |
| P/E Ratio | $146.00 | ★ $4.42 |
| Revenue Growth | 0.37 | ★ 49.25 |
| 52 Week Low | $1.07 | $1.98 |
| 52 Week High | $2.57 | $5.19 |
Technical Indicators
Market Signals| Indicator | MNTK | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 59.37 | 46.05 |
| Support Level | $1.55 | $3.87 |
| Resistance Level | $1.84 | $4.22 |
| Average True Range (ATR) | 0.09 | 0.19 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 95.56 | 14.75 |
Price Performance
Historical ComparisonAbout MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.